Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Anti-Pruritic Activity of Pioglitazone on Serotonin-Induced Scratching in Mice: Possible Involvement of Ppar-Gamma Receptor and Nitric Oxide Publisher Pubmed



Shafizadeh M1, 2 ; Rajaba A1, 2 ; Imran Khan M1, 3 ; Ostadhadi S1, 2 ; Rastegar H4 ; Dehpour A1, 2
Authors
Show Affiliations
Authors Affiliations
  1. 1. Experimental Medicine Research Center, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Department of Pharmacology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Department of Pharmacology, International Campus, Tehran University of Medical Sciences, Tehran, Iran
  4. 4. Food and Drug Research Center, Ministry of Health and Medical Education, Tehran, Iran

Source: European Journal of Pharmacology Published:2015


Abstract

Pioglitazone is a member of peroxisome proliferator-activated receptor gamma (PPARγ) agonists, particularly used in management of type II diabetes. However it also has effects in some dermatological disorders. The current study was designed to investigate the effects of oral administration of pioglitazone and the association of nitric oxide, in serotonin-induced scratching in mice. In order to produce the scratching activity, serotonin (141 nm/site) was administered intradermally in the nape of the neck. Pioglitazone in concentrations of 10, 20, 40 and 80 mg/kg, was peroral administered (p.o) as a single dose, 4 h before the serotonin injection. PPAR-γ antagonist, GW9662 (2 mg/kg, i.p); a non-specific nitric oxide synthase (NOS) inhibitor, NG-nitro-l-arginine methyl ester (l-NAME; 1 mg/kg, i.p); or a nitric oxide precursor, l-arginine (100 mg/kg, i.p.); adminstrated 15 min before pioglitazone were analyzed for anti-scratching activity. Results obtained showed that pioglitazone (40 and 80 mg/kg, p.o) reduced the scratching in a dose-dependent manner. GW9662 inverted the anti-scratching effect of pioglitazone (80 mg/kg). Acute dose of l-NAME (1 mg/kg, i.p) also prevented the anti-scratching property of pioglitazone (80 mg/kg, p.o); although l-arginine was used in sub-effective dose (100 mg/kg, i.p), however it potentiated the anti-scratching behavior when co-injected with pioglitazone (20 mg/kg, p.o). The results indicate that acute pioglitazone has an anti-scratching effect on serotonin-induced scratching in mice. It is concluded that anti-scratching outcome of acute pioglitazone is initiated via activation of PPAR-γ receptor and to some extent by the NO pathway. © 2014 Elsevier B.V. All rights reserved.
Other Related Docs
12. Discovery Approaches for Novel Dyslipidemia Drugs, Current Drug Discovery Technologies (2015)
14. Involvement of Ppar Receptors in the Anticonvulsant Effects of a Cannabinoid Agonist, Win 55,212-2, Progress in Neuro-Psychopharmacology and Biological Psychiatry (2015)